📰 Spherix Network News
Page 3 - Spherix Network News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Spherix Network. Real-time updates on events, politics, business and more.
June 15, 2023
In the third annual patient chart analysis, major treatment shifts in biologic use and average daily steroid dose were observed....
June 7, 2023
/PRNewswire/ -- Amgen launched the first U.S. adalimumab biosimilar, Amjevita, in January 2023. Yet according to the latest findings from Spherix Global...
May 23, 2023
/PRNewswire/ -- The non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH) epidemic is roughly 2.5 times greater than diabetes in the U.S....
May 17, 2023
/PRNewswire/ -- In March of 2022, the FDA approved AbbVies JAK1 inhibitor, Rinvoq (upadacitinib), for the treatment of moderate to severe ulcerative colitis...
May 8, 2023
/PRNewswire/ -- According to the Lupus Foundation of America, approximately two-thirds of people with the autoimmune condition systemic lupus erythematosus...
April 14, 2023
/PRNewswire/ -- Spherix Global Insights recently released data from their Launch Dynamix™: Trudhesa in Acute Treatment of Migraine (US) deep dive study...
April 4, 2023
/PRNewswire/ -- In 2017, Sanofi/Regeneron announced the FDA approval for the first biologic agent to treat atopic dermatitis (AD). The success of that drug,...
March 29, 2023
/PRNewswire/ -- According to Spherix Global Insights Launch Dynamix™: Vabysmo service, to no surprise, Regenerons Eylea continues to lead the charge in both...
March 27, 2023
/PRNewswire/ -- In the 32nd wave of ongoing tracking of the U.S. Renal Anemia market, Spherix surveyed 207 US nephrologists about overall patient management...
March 17, 2023
/PRNewswire/ -- When the FDA approved Rebyota, a new class of Clostridioides Difficile (C.diff) treatment, Ferring Pharmaceuticals ushered in the first...